Cleared Traditional

Gold Anchor (K213053) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K213053 · Naslund Medical AB · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2022
Decision
106d
Days
Class 2
Risk

K213053 is an FDA 510(k) clearance for the Gold Anchor. Classified as Accelerator, Linear, Medical (product code IYE), Class II - Special Controls.

Submitted by Naslund Medical AB (Huddinge, SE). The FDA issued a Cleared decision on January 6, 2022 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Naslund Medical AB devices

Submission Details

510(k) Number K213053 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 22, 2021
Decision Date January 06, 2022
Days to Decision 106 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
1d faster than avg
Panel avg: 107d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IYE Accelerator, Linear, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYE Accelerator, Linear, Medical

All 227
Devices cleared under the same product code (IYE) and FDA review panel - the closest regulatory comparables to K213053.
Aurora-RT
K213526 · Magnettx Oncology Solutions , Ltd. · May 2022
ExacTrac Dynamic
K220338 · Brainlab AG · Apr 2022
VERIQA
K213370 · Ptw-Freiburg Physikalisch-Technische-Werkstaetten · Mar 2022
MRIdian Linac System
K212958 · Viewray, Incorporated · Dec 2021
AlignRT Plus
K212583 · Vision Rt, Ltd. · Nov 2021
TaiChiB
K210921 · Our United Corporation · Nov 2021